Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 09:36 am Sale | 13G | AVROBIO INC AVRO | Camber Capital Management LP | 1,633,333 3.74% | -1,500,000 (-47.87%) | View |
2022-02-14 09:35 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,050,000 5.01% | -505,000 (-19.77%) | View |
2022-02-14 09:34 am Purchase | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Camber Capital Management LP | 16,000,000 8.63% | 3,800,000 (+31.15%) | View |
2021-11-08 08:05 am Unchanged | 13D | ORASURE TECHNOLOGIES INC OSUR | Camber Capital Management LP | 4,250,000 5.9% | 0 (Unchanged) | View |
2021-07-29 09:20 am Purchase | 13G | ORASURE TECHNOLOGIES INC OSUR | Camber Capital Management LP | 4,250,000 5.91% | 4,250,000 (New Position) | View |
2021-02-16 08:27 am Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | Camber Capital Management LP | 0 0% | -4,390,000 (Position Closed) | View |
2021-02-16 08:25 am Sale | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Camber Capital Management LP | 12,200,000 6.65% | -300,000 (-2.40%) | View |
2021-02-16 08:24 am Sale | 13G | GLYCOMIMETICS INC GLYC | Camber Capital Management LP | 2,200,000 4.6% | -1,300,000 (-37.14%) | View |
2021-02-16 08:22 am Sale | 13G | CHANGE HEALTHCARE INC CHNG | Camber Capital Management LP | 13,000,000 4.27% | -3,600,000 (-21.69%) | View |
2021-02-16 08:21 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,555,000 6.43% | 155,000 (+6.46%) | View |
2021-02-16 08:20 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 5,000,000 6.65% | 1,000,000 (+25.00%) | View |
2021-02-16 08:19 am Sale | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Camber Capital Management LP | 0 0% | -2,950,000 (Position Closed) | View |
2020-11-30 10:57 am Purchase | 13G | AVROBIO INC AVRO | Camber Capital Management LP | 3,133,333 7.56% | 3,133,333 (New Position) | View |
2020-07-13 4:06 pm Purchase | 13G | CHANGE HEALTHCARE INC CHNG | Camber Capital Management LP | 16,600,000 5.47% | 16,600,000 (New Position) | View |
2020-06-29 6:03 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,400,000 6.1% | 2,400,000 (New Position) | View |
2020-06-22 10:01 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 4,000,000 5.37% | 2,500,000 (+166.67%) | View |
2020-02-21 4:02 pm Purchase | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Camber Capital Management LP | 2,000,000 5.97% | 2,000,000 (New Position) | View |
2020-02-14 09:35 am Sale | 13G | ENDOLOGIX INC ELGX | Camber Capital Management LP | 0 0% | -9,300,000 (Position Closed) | View |
2020-02-14 09:32 am Purchase | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Camber Capital Management LP | 12,500,000 8.07% | 1,500,000 (+13.64%) | View |
2020-02-14 09:31 am Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | Camber Capital Management LP | 0 0% | -1,561,915 (Position Closed) | View |